Insulet EBITDA Margin 2010-2024 | PODD
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Insulet (PODD) over the last 10 years. The current EBITDA margin for Insulet as of June 30, 2024 is .
| Insulet EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $1.87B | $0.35B | 18.62% |
| 2024-03-31 | $1.78B | $0.32B | 18.18% |
| 2023-12-31 | $1.70B | $0.29B | 17.26% |
| 2023-09-30 | $1.56B | $0.21B | 13.35% |
| 2023-06-30 | $1.47B | $0.15B | 10.44% |
| 2023-03-31 | $1.37B | $0.09B | 6.80% |
| 2022-12-31 | $1.31B | $0.10B | 7.74% |
| 2022-09-30 | $1.24B | $0.13B | 10.14% |
| 2022-06-30 | $1.18B | $0.16B | 13.16% |
| 2022-03-31 | $1.14B | $0.21B | 18.21% |
| 2021-12-31 | $1.10B | $0.18B | 16.74% |
| 2021-09-30 | $1.04B | $0.14B | 13.21% |
| 2021-06-30 | $1.00B | $0.12B | 12.46% |
| 2021-03-31 | $0.96B | $0.12B | 12.42% |
| 2020-12-31 | $0.90B | $0.11B | 11.73% |
| 2020-09-30 | $0.87B | $0.12B | 13.26% |
| 2020-06-30 | $0.83B | $0.11B | 12.73% |
| 2020-03-31 | $0.78B | $0.08B | 10.57% |
| 2019-12-31 | $0.74B | $0.08B | 10.57% |
| 2019-09-30 | $0.69B | $0.07B | 10.37% |
| 2019-06-30 | $0.65B | $0.06B | 8.88% |
| 2019-03-31 | $0.60B | $0.05B | 8.67% |
| 2018-12-31 | $0.56B | $0.04B | 7.80% |
| 2018-09-30 | $0.53B | $0.03B | 4.91% |
| 2018-06-30 | $0.50B | $0.02B | 4.19% |
| 2018-03-31 | $0.49B | $0.01B | 2.67% |
| 2017-12-31 | $0.47B | $0.01B | 1.51% |
| 2017-09-30 | $0.44B | $0.00B | 0.68% |
| 2017-06-30 | $0.41B | $0.00B | 0.73% |
| 2017-03-31 | $0.39B | $0.01B | 1.29% |
| 2016-12-31 | $0.37B | $0.00B | 0.82% |
| 2016-09-30 | $0.35B | $-0.00B | -1.15% |
| 2016-06-30 | $0.32B | $-0.02B | -6.50% |
| 2016-03-31 | $0.30B | $-0.03B | -11.11% |
| 2015-12-31 | $0.26B | $-0.03B | -12.50% |
| 2015-09-30 | $0.20B | $-0.02B | -10.77% |
| 2015-06-30 | $0.20B | $-0.01B | -5.03% |
| 2015-03-31 | $0.21B | $-0.00B | -0.95% |
| 2014-12-31 | $0.23B | $0.00B | 1.30% |
| 2014-09-30 | $0.29B | $0.00B | 0.70% |
| 2014-06-30 | $0.27B | $-0.01B | -4.43% |
| 2014-03-31 | $0.26B | $-0.01B | -5.02% |
| 2013-12-31 | $0.25B | $-0.02B | -6.88% |
| 2013-09-30 | $0.24B | $-0.02B | -9.75% |
| 2013-06-30 | $0.23B | $-0.02B | -6.52% |
| 2013-03-31 | $0.22B | $-0.02B | -9.05% |
| 2012-12-31 | $0.21B | $-0.03B | -11.79% |
| 2012-09-30 | $0.20B | $-0.03B | -14.93% |
| 2012-06-30 | $0.19B | $-0.03B | -16.23% |
| 2012-03-31 | $0.17B | $-0.04B | -20.93% |
| 2011-12-31 | $0.15B | $-0.03B | -22.37% |
| 2011-09-30 | $0.13B | $-0.04B | -30.08% |
| 2011-06-30 | $0.11B | $-0.04B | -33.63% |
| 2011-03-31 | $0.10B | $-0.03B | -30.77% |
| 2010-12-31 | $0.10B | $-0.03B | -35.05% |
| 2010-09-30 | $0.09B | $-0.03B | -32.58% |
| 2010-06-30 | $0.08B | $-0.04B | -42.17% |
| 2010-03-31 | $0.08B | $-0.04B | -54.67% |
| 2009-12-31 | $0.07B | $-0.05B | -72.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $16.665B | $1.697B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| Surmodics (SRDX) | United States | $0.562B | 119.39 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |